comparemela.com

Stable Vision News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting

- Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – - ODYSSEY Phase 2b Clinical Trial Enrollment is On Track with Data Expected in Q3.

Clearside Biomedical Positive OASIS and Extension Study

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.